<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Patient-Derived Xenograft Seem to Have Closer Global Expression Profile to that of Patient Tumors of the Corresponding Cancer Types, than the Equivalent Cell Lines Do

Patient derived xenografts (PDXs) without in vitro manipulation are believed to mirror original patients’ histopathologic and genetic profles, thus to be predictive surrogate models for patients, with superiority over conventional cancer cell lines.